An Open-Label, Pilot Study to Evaluate the Benefits of Using Lyophilized Human Milk-Derived Nutritional Product (NeoLact 70 – 1.55 G) As an Immune-Nutritional Supplement in Premature Infants Discharged from NICU. Indian J Child Health 2021, 8 (12), 404-407. https://doi.org/10.32677/ijch.v8i12.3213.